Sunbio Technologies Information

View Top Employees from Sunbio Technologies

SunBio is a biotech company developing biosimilars, biopharmaceuticals, and medicaldevices based on our proprietary technologies of pegylation. SunBios biosimilar product, PEG-filgrastim, has been marketed in India since 2008, and gained a marketing approval in Canada in 2018, and gained a marketingapproval in EU in 2018. Products currently under development are a treatment for xerostomia, a visco-supplement for arthritic knee, a treatment for brain stroke, and a treatment for diabetic retinopathy. SunBio offers a variety of PEG product, or activated PEG derivatives, that are crucial ingredients in the art of PEGylation. GMP manufacturing facility for manufacturing ofPEG products is in operation.

Website	http://www.sunbio.com
Revenue	$5.4 million
Employees	5 (0 on RocketReach)
Phone	+82 32-812-5467
Fax	+82 31-423-5430
Industry	Textile Manufacturing, Hospitals & Clinics, Healthcare
Keywords	Biosimilars, Biosimilar Development, Protein Engineering, Bioprocessing, Biologics, Biotechnology, Drug Development, Therapeutic Proteins, Medical Devices, Drug Delivery, Drug Manufacturing, Pharmaceutical Research, Pharmaceutical, Pharmaceutical Manufacturing, Clinical Development, Regulatory Affairs
Competitors	Roche, Thermo Fisher Scientific, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Celerion, Sierra Sciences +42 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 62 Companies, NAICS Code 32 Companies, NAICS Code 6215 Companies, NAICS Code 3254 Companies, NAICS Code 62151 Companies, NAICS Code 325 Companies, NAICS Code 621 Companies, NAICS Code 32541 Companies